The NIAAA Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5) (42) was the diagnostic interview. AUDADIS-5 measures drug and alcohol use (e.g., onset, frequency), DSM-5 drug, alcohol and nicotine use disorders, and selected psychiatric disorders in the last 12 months and prior to the last 12 months. DSM-5 cannabis use disorder diagnoses required ≥2 of 11 criteria within a 12-month period. Twelve-month and prior diagnoses were aggregated to form lifetime diagnoses. Consistent with DSM-5, cannabis use disorders were classified as mild (2–3 criteria), moderate (4–5 criteria) or severe (≥6 criteria).
